Closing the Loop: Outcome Metrics and Final Reflections on Tardive Dyskinesia Management

In the final episode, 'Closing the Loop: Outcome Metrics and Final Reflections on Tardive Dyskinesia Management,' the panelists explored the following critical questions:

What metrics or feedback mechanisms can track the success of interventions aimed at improving tardive dyskinesia (TD) recognition and therapy persistence?

What are your final takeaways from today's discussion?

Led by the moderator, the panelists discussed key metrics for tracking the success of TD interventions, emphasizing the importance of baseline Abnormal Involuntary Movement Scale (AIMS) assessments, ongoing multidisciplinary observation, and caregiver engagement, while noting that vesicular monoamine transporter 2 (VMAT2) inhibitors are associated with a significant decrease in AIMS scores. Melissa Cloyd, Jamie Kneebusch, and Farah Khorassani highlighted the value of evaluating both holistic AIMS scores and specific affected body regions, asking patients directly about functional impact, and using video documentation to help patients visualize improvement over time, while setting realistic expectations that symptom reduction, rather than complete resolution, is often the more likely outcome. In their final takeaways, the panelists underscored the importance of multidisciplinary education and collaboration, encouraged clinicians to identify and build relationships with specialty pharmacies, emphasized that TD management requires continuous communication between pharmacists, prescribers, and caregivers, and called for greater attention to baseline monitoring and accurate differentiation of movement disorders to ensure patients receive appropriately targeted treatment.

Throughout the conversation, the experts provided a comprehensive reflection on the field and the factors that may shape how clinicians approach care moving forward.

Thank you for watching this Peer Exchange series on tardive dyskinesia. Please subscribe to our newsletter for information on upcoming video series.